跳至主要内容
临床试验/EUCTR2005-003749-15-GB
EUCTR2005-003749-15-GB进行中(未招募)不适用

Investigation of the effectiveness of oral lorazepam in managing preoperative dental anxiety in phobic dental patients-A pilot study - Oral lorazepam for managing dental anxiety.

Merck, Sharp & Dohme-Clinical Pharmacology,Europe0 个研究点目标入组 36 人开始时间: 2005年10月14日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients referred to the sedation department due to disproportionate dental anxiety
  • Score 15+ on a Corah dental Anxiety scale
  • Aged 18-50
  • Able to: attend Newcastle Dental Hospital for treatment; understand the trial; give written consent;take the medication twice daily, in divided doses; avoid driving/working/drinking for the 3 day trial period
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Refusal to participate
  • Corah score <15
  • Inability to understand the consent/questionnaires
  • Inability to attend within the time of the trial
  • Unable to take the medication
  • Unable to restrain from driving/drinking for the 3 days of the trial.

研究者

发起方
Merck, Sharp & Dohme-Clinical Pharmacology,Europe

相似试验

Investigation of the effectiveness of oral lorazepam... | 临床试验